Marion Sylvain

Dr. Marion Sylvain

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Journal of Hand and Microsurgery
Verified
Journal Article
Closed access
OSOmar El Sewify
Omar El Sewify
SDShaishav Datta
Shaishav Datta
JLJack Legler
Jack Legler
MSMarion Sylvain
Marion Sylvain
ACAndre Cheah
Andre Cheah
JEJohnny Ionut Efanov
Johnny Ionut Efanov

1 July 2025 in Journal of Hand and Microsurgery
Verified
Journal Article
Closed access
OSOmar El Sewify
Omar El Sewify
GBGabriel Bouhadana
Gabriel Bouhadana
ELElisabeth Lorange
Elisabeth Lorange
MSMarion Sylvain
Marion Sylvain
PNPanu H. Nordback
Panu H. Nordback
JEJohnny Ionut Efanov
Johnny Ionut Efanov

31 August 2026 in Plastic Surgery
Verified
Journal Article
Open access
OSOmar El Sewify
Omar El Sewify
AGAndrew Gorgy
Andrew Gorgy
MSMarion Sylvain
Marion Sylvain
JLJack Legler
Jack Legler
DZDino Zammit
Dino Zammit
Introduction: Preoperative simulation technologies are increasingly utilized in plastic surgery to enhance surgical planning and patient communication. While their technical benefits have been established, the impact on patient-reported outcomes (PROs), in particular satisfaction and perceived accuracy, remain underexplored. This systematic review evaluated the effect of preoperative simulation on patient-reported satisfaction, decision-making, and perceived accuracy in breast and facial aesthetic plastic surgery. Methods: A systematic search of MEDLINE, Embase, and Cochrane databases up to April 2025 identified studies reporting PROs in adult patients undergoing breast (aesthetic or reconstructive) or facial aesthetic surgery with preoperative simulation. Data on demographics, simulation type, satisfaction, accuracy, and complications were extracted and analyzed. Results: Seventeen studies (1333 patients; 970 simulation, 363 control) met inclusion criteria. Breast surgery patients using simulation showed higher satisfaction with appearance (Breast-Q: 75.0 vs 58.1), surgical outcomes (84.9% vs 78.8%), and psychosocial well-being. Simulation patients reported higher satisfaction with the simulation experience (95.4%) and greater trust in their surgeon (95.2%), with lower complication rates (4.1% vs 41.5%). In facial surgery, simulation users demonstrated greater overall satisfaction (79.2% vs 67.3%) and improved understanding of outcomes. Perceived accuracy was higher in breast (91.0%) than facial surgery (74.1%). Across procedures, simulation enhanced shared decision-making and surgeon-patient rapport. Conclusion: Current evidence suggests that preoperative simulation may enhance patient satisfaction, trust, and engagement in plastic surgery, particularly in breast procedures. However, findings are based on heterogeneous studies with diverse patient populations, simulation technologies, and outcome measures. Further prospective comparative studies using standardized PRO measures are needed to better define the role of preoperative simulation across aesthetic and reconstructive plastic surgery.

30 September 2026 in Plastic Surgery
Verified
Journal Article
Open access
OSOmar El Sewify
Omar El Sewify
MSMarion Sylvain
Marion Sylvain
CTCory Tremblay
Cory Tremblay
HRHelene Retrouvey
Helene Retrouvey
AGAmmara Ghumman
Ammara Ghumman
Introduction: Sentinel lymph node biopsy (SLNB) is increasingly used to stage cutaneous squamous cell carcinoma (cSCC), particularly in high-risk cases, though its diagnostic accuracy remains debated. This systematic review aims to evaluate SLNB detection rates, diagnostic accuracy, complications and predictors of positivity in patients with non-mucosal cSCC. Methods: Following PRISMA guidelines, Medline, Embase, Scopus and Cochrane Library were searched to January 2025. Studies reporting SLNB outcomes in histologically confirmed cSCC were included. Pediatric and mucosal/anogenital cases were excluded. Data on demographics, tumour characteristics, SLNB outcomes and complications were extracted. Comparisons between SLNB-positive, negative and false-negative groups were performed ( p < 0.05). Results: Forty-four studies (3043 patients, 3050 lesions) were included. Among 2956 patients undergoing SLNB, nodes were identified in 96.9%, with positivity in 10.9%. False negatives occurred in 1.7% of the cases (rate 13.2%). SLNB-positive patients had larger tumours (4.24 vs 2.88 cm, p < 0.0001) and deeper invasion (9.81 vs 4.75 mm, p = 0.0007), higher rates of perineural invasion ( p = 0.0436), poor differentiation ( p = 0.009) and more T2 disease ( p = 0.04). No significant differences were found for sex ( p = 0.5), immunosuppression ( p = 0.068) or tumour location ( p = 0.1), though immunosuppression was more prevalent in SLNB-positive cases. Recurrence (24.3% vs 4.2%) and disease-specific mortality (18.2% vs 3.7%) were higher in SLNB-positive patients ( p < 0.0002). Complication rates were low (3.2%). Conclusion: SLNB demonstrates high detection but notable false negative rates in cSCC. Positive SLNB correlates with aggressive tumour features and worse outcomes. SLNB may assist staging in high-risk patients but should be used selectively, with close surveillance in SLNB-negative cases.